Allen Andrew R
PRESIDENT AND CEO at Gritstone bio, Inc.; Officer at Clovis Oncology, Inc.
- Sold, on record
- $6.8M
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 16, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Gritstone bio, Inc.PRESIDENT AND CEO
- Clovis Oncology, Inc.Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Clovis Oncology, Inc.102,594 shares
- Gritstone bio, Inc.24,263 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Clovis Oncology, Inc.UnusualJun 5 2013
Sold 22,594 shares at $68.54 ($1.5M)
Allen Andrew R, Officer
Sold 100% of holdings ($1.5M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Clovis Oncology, Inc.UnusualJan 16 +590 days
Sold 80,000 shares at $65.64 ($5.3M)
Allen Andrew R, Officer
Sold 44% of holdings ($11.9M position)101,919 shares leftFiling
- 3 Form 4 sale Gritstone bio, Inc.No planMay 16 +3408 days
Sold 24,263 shares at $0.75 ($18k)
Allen Andrew R, PRESIDENT AND CEO
No 10b5-1 planSold 2.4% of holdings ($757k position)985,360 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | Gritstone bio, Inc. | PRESIDENT AND CEO | Form 4 sale | 24,263 | $18k | 2.4% | No plan | SEC |
| Jan 16, 2015 | Clovis Oncology, Inc. | Officer | Form 4 sale | 80,000 | $5.3M | 44.0% | Unusual | SEC |
| Jun 5, 2013 | Clovis Oncology, Inc. | Officer | Form 4 sale | 22,594 | $1.5M | 100.0% | Unusual | SEC |